SCHEMBL2044811

SCHEMBL2044811

CCCCCCCCc1ccc(CC2CCCC2(N)C(=O)O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
S1PR1 P21453 4/20 0.43
S1PR3 Q99500 3/20 0.43
S1PR4 O95977 2/20 0.43
S1PR5 Q9H228 2/20 0.43
ARG1 P05089 3/20 0.43
ARG2 P78540 2/20 0.43
SPHK1 Q9NYA1 5/20 0.43
RARB P10826 4/20 0.43
SPHK2 Q9NRA0 4/20 0.43
EPHX1 P07099 1/20 0.43
EPHX2 P34913 1/20 0.43
MEN1 O00255 1/20 0.43
RARA P10276 1/20 0.43
MAPT P10636 1/20 0.43
MTOR P42345 1/20 0.43
KMT2A Q03164 1/20 0.43
S1PR2 O95136 1/20 0.42
THRA P10827 1/20 0.42
THRB P10828 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12645530 0.81 SPHK1 (0.46) ALDH1A1SPHK1SPHK2
SCHEMBL13880925 0.80 SPHK1 (0.43) ALDH1A1S1PR1S1PR3S1PR4S1PR5
SCHEMBL13880930 0.80 SPHK1 (0.43) ALDH1A1S1PR1S1PR3S1PR4S1PR5
SCHEMBL588360 0.80 SPHK1 (0.43) ALDH1A1S1PR1S1PR3S1PR4S1PR5
SCHEMBL13880923 0.80 SPHK1 (0.43) ALDH1A1S1PR1S1PR3S1PR4S1PR5
SCHEMBL13880785 0.80 SPHK1 (0.43) ALDH1A1S1PR1S1PR3S1PR4S1PR5
SCHEMBL25532846 0.80 SPHK1 (0.43) ALDH1A1S1PR1S1PR3S1PR4S1PR5
SCHEMBL12588104 0.80 SPHK1 (0.45) ALDH1A1S1PR1S1PR3S1PR4S1PR5
SCHEMBL12588108 0.80 SPHK1 (0.45) ALDH1A1S1PR1S1PR3S1PR4S1PR5
SCHEMBL12588107 0.80 SPHK1 (0.45) ALDH1A1S1PR1S1PR3S1PR4S1PR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960588-B2 Benzyl cycloalkyl sphingosine 1-phosphate receptor modulators UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2011-06-14 US disclosed
US-20100249074-A1 BENZYL-CYCLOALKYL SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATORS UNIVERSITY OF VIRGINIA PATENT FOUNDATION 2010-09-30 US disclosed
EP-2203409-A2 BENZYL-CYCLOALKYL SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATORS University Of Virginia Patent Foundation (US) 2010-07-07 EP disclosed
WO-2009043013-A2 BENZYL-CYCLOALKYL SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATORS UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2009-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249074-A1 BENZYL-CYCLOALKYL SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATORS S1PR1, S1PR3, S1PR4 ALDH1A1 3756/4885S1PR1 1/4885S1PR3 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.